Journal
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
Volume 12, Issue 3, Pages 196-202Publisher
KOREAN COLL NEUROPSYCHOPHARMACOLOGY
DOI: 10.9758/cpn.2014.12.3.196
Keywords
Serotonin; Mental disorders; Positron-emission tomography; Single photon emission computed tomography
Categories
Funding
- National Science Council of Taiwan [NSC 95-2314-B-006-115-MY2, NSC 97-2314-B-006-006-MY3, NSC 100-2314-B-006-041-MY3]
- Atomic Energy Council of Taiwan [INER 962014L, INER 970930L, INER NL81376]
- National Cheng Kung University Hospital [NCKUH-9903019, NCKUH-10104019]
- Headquarters of University Advancement at the National Cheng Kung University - Ministry of Education, Taiwan, ROC
Ask authors/readers for more resources
Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmacological treatments, Functional neuroimaging techniques, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
